Office of the Director; Notice of Meeting, 23446-23447 [2023-08071]
Download as PDF
23446
Federal Register / Vol. 88, No. 73 / Monday, April 17, 2023 / Notices
Abstract: This collection of
information is necessary to enable HHS
to garner customer and stakeholder
feedback. Information will be collected
from our customers and stakeholders
from the concept phase to the end of the
product life cycle. This will help ensure
that users have an effective, efficient,
and satisfying experience with HHS
communications products. If this
information is not collected, vital
feedback on HHS communications will
be unavailable, preventing programs
from developing communications
products that meets the needs of the
audience and demonstrating impact of
the communications products
developed.
Type of respondent; frequency
(annual, quarterly, monthly, etc.); and
the affected public (individuals, public
or private businesses, state or local
governments, etc.)
ANNUALIZED BURDEN HOUR TABLE
Forms
(if necessary)
Number of
respondents
Number of
responses per
respondents
Average
burden per
response
Total burden
hours
HHS communications products .......................................................................
1,000,000
1
30/60
500,000
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
[FR Doc. 2023–08063 Filed 4–14–23; 8:45 am]
BILLING CODE 4150–25–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–0990–0379]
Agency Father Generic Information
Collection Request; 60-Day Public
Comment Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before June 16, 2023.
ADDRESSES: Submit your comments to
Sherrette.Funn@hhs.gov or PRA@
hhs.gov by calling (202) 264–0041.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 0990–0379–
60D, and project title for reference, to
Sherrette Funn, the Reports Clearance
Officer, Sherrette.funn@hhs.gov, or call
202–202–264–0041.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: Generic
Clearance for the Collection of
Qualitative Feedback on Agency Service
Delivery (Online Customer Surveys).
Type of Collection: Father Generic
ICR.
OMB No.: 0990–0379—OS/ASPA.
Abstract: This collection of
information is necessary to enable the
Agency to garner customer and
stakeholder feedback in an efficient,
timely manner, in accordance with our
commitment to improving service
delivery. The information collected
from our customers and stakeholders
will help ensure that users have an
effective, efficient, and satisfying
experience with the Agency’s programs.
This feedback will provide insights into
customer or stakeholder perceptions,
experiences and expectations, provide
an early warning of issues with service,
or focus attention on areas where
communication, training or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing, collaborative and
actionable communications between the
Agency and its customers and
stakeholders.
Type of respondent; frequency
(annual, quarterly, monthly, etc.); and
the affected public (individuals, public
or private businesses, state or local
governments, etc.).
lotter on DSK11XQN23PROD with NOTICES1
ANNUALIZED BURDEN HOUR TABLE
Forms
(if necessary)
Number of
respondents
Number of
responses per
respondents
Average
burden per
response
Total burden
hours
Website Customer Satisfaction Survey ...........................................................
3,000,000
1
10/60
500,000
Sherrette A. Funn,
Office of the Secretary, Paperwork Reduction
Act Reports Clearance Officer.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2023–08032 Filed 4–14–23; 8:45 am]
National Institutes of Health
BILLING CODE 4150–25–P
Office of the Director; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
VerDate Sep<11>2014
16:57 Apr 14, 2023
Jkt 259001
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
meeting of the NIH Clinical Center
Research Hospital Board.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend as well
as those who need special assistance,
such as sign language interpretation or
other reasonable accommodations,
should notify one of the Contact Persons
listed below in advance of the meeting.
E:\FR\FM\17APN1.SGM
17APN1
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 73 / Monday, April 17, 2023 / Notices
The meeting can be accessed from the
NIH Videocast https://videocast.
nih.gov/ and CCRHB https://ccrhb.
od.nih.gov/meetings.html websites.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Name of Committee: NIH Clinical Center
Research Hospital Board.
Date: June 16, 2023.
Time: 9:30 a.m. to 1:00 p.m.
Agenda: NIH and Clinical Center (CC)
Leadership Announcements, CC CEO Update
of Recent Activities and Organizational
Priorities, Status Report on Key CC Strategic
Plan Initiatives, and Other Business of the
Clinical Center Research Hospital Board
(CCRHB).
Place: National Institutes of Health,
Building 31, Conference Room 6C02 A & B,
9000 Rockville Pike, Bethesda, MD 20892.
Contact Persons: Patricia Piringer, RN,
MSN (C), National Institutes of Health
Clinical Center, 10 Center Drive, Bethesda,
MD 20892, ppiringer@cc.nih.gov, (301) 402–
2435, (202) 460–7542 (direct).
Natascha Pointer, Management Analyst,
Executive Assistant to Dr. Gilman, Office of
the Chief Executive Officer, National
Institutes of Health Clinical Center, 10 Center
Drive, Bethesda, MD 20892, npointer@
cc.nih.gov, (301) 496–4114, (301) 402–2434
(direct).
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person(s) listed
on this notice. The statement should include
the name, address, telephone number and,
when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Meeting information is also available on
the CCRHB website: https://
www.ccrhb.od.nih.gov/ where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
National Center for Advancing
Translational Sciences; Notice of
Meeting
National Institutes of Health
Dated: April 12, 2023.
Patricia B. Hansberger,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–08071 Filed 4–14–23; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
16:57 Apr 14, 2023
Jkt 259001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Center for
Advancing Translational Sciences
Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend as well
as those who need special assistance,
such as sign language interpretation or
other reasonable accommodations,
should notify the Contact Person listed
below in advance of the meeting. The
open session will be videocast and can
be accessed from the NIH Videocasting
website (https://videocast.nih.gov/).
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Advisory
Council.
Date: May 25, 2023.
Closed: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, Building B, Room 377, 9800 Medical
Center Drive, Rockville, MD 20850.
Open: 1:00 p.m. to 6:00 p.m.
Agenda: Report from the Center Director,
2024 NCATS Strategic Plan, Program
Updates (2).
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, Building B, Room 377, 9800 Medical
Center Drive, Rockville, MD 20850.
Contact Person: Anna L. Ramsey-Ewing,
Ph.D., Executive Secretary, National Center
for Advancing Translational Sciences, 1
Democracy Plaza, Room 1072, Bethesda, MD
20892, 301–435–0809, anna.ramseyewing@
nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice no later than 15 days after the
meeting at NCATSCouncilInput@
mail.nih.gov. The statement should include
the name, address, telephone number and
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
23447
when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: April 12, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–08074 Filed 4–14–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Request for Information (RFI): Inviting
Feedback on the NIH Office of Disease
Prevention Strategic Plan for Fiscal
Years 2024–2028
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The National Institutes of
Health (NIH), Office of the Director,
Office of Disease Prevention (ODP) is
requesting public comment on its draft
strategic plan for Fiscal Years 2024–
2028 (FY24–28), Prevention Research:
Creating a Healthier Future for All. ODP
invites feedback on its proposed
priorities from prevention researchers in
academia and industry, health care
providers, patient advocacy
organizations, community-based
organizations, health service
organizations, scientific or professional
organizations, trainees and early-stage
investigators, federal agencies, those
employed by NIH or at institutions
receiving NIH support, and the general
public. Organizations are strongly
encouraged to submit a single response
that reflects the views of the
organization and membership as a
whole.
SUMMARY:
ODP’s RFI is open for public
comment through May 22, 2023.
Responses must be received by 11:59
DATES:
E:\FR\FM\17APN1.SGM
17APN1
Agencies
[Federal Register Volume 88, Number 73 (Monday, April 17, 2023)]
[Notices]
[Pages 23446-23447]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-08071]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the NIH Clinical Center
Research Hospital Board.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
as well as those who need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify one of
the Contact Persons listed below in advance of the meeting.
[[Page 23447]]
The meeting can be accessed from the NIH Videocast https://videocast.nih.gov/ and CCRHB https://ccrhb.od.nih.gov/meetings.html
websites.
Name of Committee: NIH Clinical Center Research Hospital Board.
Date: June 16, 2023.
Time: 9:30 a.m. to 1:00 p.m.
Agenda: NIH and Clinical Center (CC) Leadership Announcements,
CC CEO Update of Recent Activities and Organizational Priorities,
Status Report on Key CC Strategic Plan Initiatives, and Other
Business of the Clinical Center Research Hospital Board (CCRHB).
Place: National Institutes of Health, Building 31, Conference
Room 6C02 A & B, 9000 Rockville Pike, Bethesda, MD 20892.
Contact Persons: Patricia Piringer, RN, MSN (C), National
Institutes of Health Clinical Center, 10 Center Drive, Bethesda, MD
20892, [email protected], (301) 402-2435, (202) 460-7542
(direct).
Natascha Pointer, Management Analyst, Executive Assistant to Dr.
Gilman, Office of the Chief Executive Officer, National Institutes
of Health Clinical Center, 10 Center Drive, Bethesda, MD 20892,
[email protected], (301) 496-4114, (301) 402-2434 (direct).
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person(s)
listed on this notice. The statement should include the name,
address, telephone number and, when applicable, the business or
professional affiliation of the interested person.
In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a
meeting on campus or at an off-campus federal facility will be asked
to show one form of identification (for example, a government-issued
photo ID, driver's license, or passport) and to state the purpose of
their visit.
Meeting information is also available on the CCRHB website:
https://www.ccrhb.od.nih.gov/ where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: April 12, 2023.
Patricia B. Hansberger,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-08071 Filed 4-14-23; 8:45 am]
BILLING CODE 4140-01-P